{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:08:42Z","timestamp":1778022522559,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"UK National Institute for Health Research Biomedical Research Centre in Ophthalmology"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ajo.2010.03.010","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T04:30:55Z","timestamp":1276057855000},"page":"179-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Sirolimus and Mycophenolate as Combination Prophylaxis in Corneal Transplant Recipients at High Rejection Risk"],"prefix":"10.1016","volume":"150","author":[{"given":"Marc-Antoine","family":"Chatel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F.P.","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ajo.2010.03.010_bib1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/01.tp.0000185197.37824.35","article-title":"How effective is penetrating corneal transplantation?","volume":"81","author":"Williams","year":"2006","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ajo.2010.03.010_bib2","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.ajo.2005.07.024","article-title":"The impact of corneal allograft rejection on the long-term outcome of corneal transplantation","volume":"140","author":"Coster","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2010.03.010_bib3","first-page":"1210","article-title":"Influence of donor and histocompatibility factors on conreal graft outcome","volume":"58","author":"Vail","year":"1994","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.ajo.2010.03.010_bib4","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.1992.01080220054021","article-title":"Effectiveness of histocompatibility matching in high-risk corneal transplantation","volume":"110","year":"1992","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2010.03.010_bib5","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.4049\/jimmunol.157.6.2262","article-title":"Peptide-specific T cell clonal expansion in vivo following immunization in the eye, an immune-privileged site","volume":"157","author":"Egan","year":"1996","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.ajo.2010.03.010_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-5155(97)80001-9","article-title":"Involvement of CD8+ RT1B+ and CD4+ RT1B+ cells of cervical lymph nodes in the immune response after corneal transplantation in the rat","volume":"41","author":"Okada","year":"1997","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2010.03.010_bib7","first-page":"1293","article-title":"The critical role of lymph nodes in corneal alloimmunization and graft rejection","volume":"42","author":"Yamagami","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2010.03.010_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0161-6420(13)31253-6","article-title":"Systemic cyclosporine in high-risk keratoplasty","volume":"101","author":"Hill","year":"1994","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"10.1016\/j.ajo.2010.03.010_bib9","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1007\/BF02343059","article-title":"Systemic ciclosporin A in high-risk keratoplasties","volume":"234","author":"Reinhard","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2010.03.010_bib10","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1136\/bjo.85.12.1464","article-title":"Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study","volume":"85","author":"Poon","year":"2001","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2010.03.010_bib11","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/bjo.86.9.988","article-title":"Systemic cyclosporine A in high failure risk, repeated corneal transplantation","volume":"86","author":"Rumelt","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2010.03.010_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bjo.2006.097428","article-title":"Tacrolimus immunosuppression in high-risk corneal grafts","volume":"91","author":"Joseph","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2010.03.010_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s004170100285","article-title":"Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial","volume":"239","author":"Reinhard","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2010.03.010_bib14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/01.tp.0000191291.71003.1b","article-title":"An open prospective pilot study on the use of rapamycin after penetrating high-risk keratoplasty","volume":"81","author":"Birnbaum","year":"2006","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.ajo.2010.03.010_bib15","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/j.1600-6143.2008.02285.x","article-title":"Aqueous humour alloreactive cell phenotypes, cytokines and chemokines in corneal allograft rejection","volume":"8","author":"Flynn","year":"2008","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajo.2010.03.010_bib16","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2002-06-1688","article-title":"Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression","volume":"101","author":"Woltman","year":"2003","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ajo.2010.03.010_bib17","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/TP.0b013e3181874a36","article-title":"Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin","volume":"86","author":"Heidt","year":"2008","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ajo.2010.03.010_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00007890-199402150-00021","article-title":"Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors","volume":"57","author":"Cooper","year":"1994","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ajo.2010.03.010_bib19","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1600-6143.2006.01332.x","article-title":"Rapamycin induces caspase-independent cell death in human monocytes","volume":"6","author":"Mercalli","year":"2006","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.ajo.2010.03.010_bib20","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/archopht.1994.01090230085026","article-title":"Rapamycin inhibits corneal allograft rejection and neovascularization","volume":"112","author":"Olsen","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2010.03.010_bib21","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1600-6143.2004.00627.x","article-title":"De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years","volume":"4","author":"Flechner","year":"2004","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajo.2010.03.010_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","article-title":"Mycophenolate mofetil for ocular inflammation","volume":"149","author":"Daniel","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2010.03.010_bib23","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1111\/j.1600-6143.2004.00612.x","article-title":"Comparative effect of sirolimus and mycophenolate mofetil on erythrpoeisis in kidney transplant patients","volume":"4","author":"Augustine","year":"2004","journal-title":"Am J Transplant"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939410002242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939410002242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:01:19Z","timestamp":1757595679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939410002242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0002939410002242"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2010.03.010","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sirolimus and Mycophenolate as Combination Prophylaxis in Corneal Transplant Recipients at High Rejection Risk","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2010.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}